<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR109">
 <label>109.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khoshnejad</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Patel</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Wojtak</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Kudchodkar</surname>
    <given-names>SB</given-names>
   </name>
   <name>
    <surname>Humeau</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Lyssenko</surname>
    <given-names>NN</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Development of novel DNA-encoded PCSK9 monoclonal antibodies as lipid-lowering therapeutics</article-title>
  <source>Mol Ther</source>
  <year>2019</year>
  <volume>27</volume>
  <issue>1</issue>
  <fpage>188</fpage>
  <lpage>199</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ymthe.2018.10.016</pub-id>
  <?supplied-pmid 30449662?>
  <pub-id pub-id-type="pmid">30449662</pub-id>
 </element-citation>
</ref>
